Malignant screening endometrial cancer vulvar neoplasms. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy7

Endometrium Cell Line, Tumor Tumor Cells, Cultured Myometrium Lymph Nodes Neoplastic Stem Cells Pelvis

Organisms1

Diseases78

Vulvar Neoplasms Endometrial Neoplasms Carcinoma, Endometrioid Endometrial Hyperplasia Neoplasms Pancreatic Neoplasms Ovarian Neoplasms Uterine Neoplasms Neoplasm Invasiveness Breast Neoplasms Lung Neoplasms Adenocarcinoma Cystadenocarcinoma, Serous Genital Neoplasms, Female Neoplasms, Multiple Primary Carcinoma Neoplasms, Second Primary Prostatic Neoplasms Colonic Neoplasms Neoplasm Metastasis Colorectal Neoplasms, Hereditary Nonpolyposis Genetic Predisposition to Disease Stomach Neoplasms Adenocarcinoma, Clear Cell Cystadenocarcinoma, Papillary Neoplasm Recurrence, Local Skin Neoplasms Neoplasms, Cystic, Mucinous, and Serous Uterine Cervical Neoplasms Colorectal Neoplasms Adenocarcinoma, Mucinous Adenocarcinoma, Papillary Kidney Neoplasms Thyroid Neoplasms Liver Neoplasms Urinary Bladder Neoplasms Disease Progression Mixed Tumor, Mullerian Neoplasms, Hormone-Dependent Carcinoma, Squamous Cell Neoplasms, Radiation-Induced Carcinoma, Papillary Gastrointestinal Neoplasms Precancerous Conditions Cell Transformation, Neoplastic Neoplasms, Glandular and Epithelial Bone Neoplasms Vaginal Neoplasms Carcinosarcoma Microsatellite Instability Neoplasms, Experimental Carcinoma, Pancreatic Ductal Mouth Neoplasms Rectal Neoplasms Uterine Hemorrhage Testicular Neoplasms Adenoma Carcinoma, Non-Small-Cell Lung Mixed Tumor, Mesodermal Esophageal Neoplasms Peritoneal Neoplasms Head and Neck Neoplasms Carcinoma, Adenosquamous Obesity Myeloproliferative Disorders Neovascularization, Pathologic Pelvic Neoplasms Cystadenoma Intestinal Neoplasms Polyps Parotid Neoplasms Lymphoma Appendiceal Neoplasms Endocrine Gland Neoplasms Neoplasms, Connective and Soft Tissue Neoplasms, Plasma Cell Nose Neoplasms Cystadenoma, Mucinous

Chemicals and Drugs51

Tumor Markers, Biological Neoplasm Proteins Tamoxifen Estrogens DNA, Neoplasm Receptors, Progesterone Antineoplastic Agents, Hormonal Progestins Receptors, Estrogen Antineoplastic Agents RNA, Messenger Antigens, Neoplasm Estrogen Antagonists Contraceptives, Oral PTEN Phosphohydrolase MutS Homolog 2 Protein Cancer Vaccines Estrogen Receptor alpha Estrogen Receptor Modulators Selective Estrogen Receptor Modulators RNA, Small Interfering Tumor Suppressor Protein p53 Receptor, erbB-2 Nuclear Proteins Tumor Suppressor Proteins Paclitaxel RNA, Neoplasm DNA-Binding Proteins Adaptor Proteins, Signal Transducing Proto-Oncogene Proteins Proto-Oncogene Proteins c-akt MicroRNAs Anticarcinogenic Agents Toremifene Cisplatin Estradiol TOR Serine-Threonine Kinases Arylsulfotransferase Raloxifene Antibodies, Monoclonal Antineoplastic Agents, Phytogenic CA-125 Antigen Phytoestrogens Contraceptives, Oral, Hormonal Prostate-Specific Antigen Ki-67 Antigen Aromatase Estradiol Congeners Estrogens, Catechol Transcription Factors Receptor, Epidermal Growth Factor

Analytical, Diagnostic and Therapeutic Techniques and Equipment64

Neoplasm Staging Early Detection of Cancer Hysterectomy Risk Factors Prognosis Case-Control Studies Risk Immunohistochemistry Retrospective Studies Survival Rate Odds Ratio Survival Analysis Estrogen Replacement Therapy Prospective Studies Follow-Up Studies Reverse Transcriptase Polymerase Chain Reaction Incidence Risk Assessment Registries Neoplasm Grading Salpingectomy Cohort Studies Disease-Free Survival Antineoplastic Combined Chemotherapy Protocols Gene Expression Profiling Blotting, Western Body Mass Index Neoplasm Transplantation Sensitivity and Specificity Lymph Node Excision Logistic Models Xenograft Model Antitumor Assays SEER Program Kaplan-Meier Estimate Immunoenzyme Techniques Multivariate Analysis Hormone Replacement Therapy Chemotherapy, Adjuvant Polymerase Chain Reaction Oligonucleotide Array Sequence Analysis Treatment Outcome Neoplasms, Experimental Confidence Intervals Combined Modality Therapy Questionnaires Tissue Array Analysis Radiotherapy, Adjuvant Molecular Targeted Therapy Gynecologic Surgical Procedures Transplantation, Heterologous Predictive Value of Tests Drug Screening Assays, Antitumor Obesity Biopsy Radiotherapy Tumor Burden Genetic Testing DNA Mutational Analysis Dilatation and Curettage Clinical Trials as Topic Reproducibility of Results Transfection Gene Knockdown Techniques Reproductive History

Psychiatry and Psychology1

Phenomena and Processes47

Gene Expression Regulation, Neoplastic Risk Postmenopause Genetic Predisposition to Disease Odds Ratio Mutation DNA Methylation Genotype Germ-Line Mutation Cell Proliferation Drug Resistance, Neoplasm Body Mass Index Sensitivity and Specificity Menopause Polymorphism, Genetic Apoptosis Microsatellite Repeats Cell Growth Processes Gene Silencing Microsatellite Instability Premenopause Parity Down-Regulation Cell Division Genes, Tumor Suppressor Cell Survival Cell Cycle Signal Transduction Promoter Regions, Genetic Obesity Dose-Response Relationship, Drug Diet DNA Mismatch Repair Cell Movement Polymorphism, Single Nucleotide Alleles Time Factors Genes, Neoplasm Base Sequence Transfection Gene Expression Up-Regulation Genes, p53 RNA Interference Loss of Heterozygosity Phenotype Haplotypes

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Survival

Technology, Industry, Agriculture1

Information Science6

Survival Rate Incidence Registries SEER Program Questionnaires Base Sequence

Named Groups2

Survivors European Continental Ancestry Group

Health Care32

Risk Factors Case-Control Studies Risk Retrospective Studies Survival Rate Odds Ratio Survival Analysis Prospective Studies Follow-Up Studies Incidence Risk Assessment Registries Age Factors Cohort Studies Disease-Free Survival Body Mass Index Sensitivity and Specificity Logistic Models SEER Program Kaplan-Meier Estimate Multivariate Analysis Treatment Outcome Confidence Intervals Questionnaires Parity National Cancer Institute (U.S.)Predictive Value of Tests Genetic Testing Clinical Trials as Topic Reproducibility of Results Reproductive History Confounding Factors (Epidemiology)

Geographicals4

United States Sweden China Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Named Groups Health Care Geographicals

Vulvar Neoplasms Endometrial Neoplasms Carcinoma, Endometrioid Endometrial Hyperplasia Neoplasms Pancreatic Neoplasms Ovarian Neoplasms Uterine Neoplasms Neoplasm Staging Early Detection of Cancer Neoplasm Invasiveness Hysterectomy Endometrium Breast Neoplasms Lung Neoplasms Risk Factors Prognosis Adenocarcinoma Gene Expression Regulation, Neoplastic Cystadenocarcinoma, Serous Tumor Markers, Biological Case-Control Studies Genital Neoplasms, Female Risk Neoplasms, Multiple Primary Neoplasm Proteins Carcinoma Tamoxifen Cell Line, Tumor Estrogens Neoplasms, Second Primary Prostatic Neoplasms Immunohistochemistry Postmenopause Colonic Neoplasms Neoplasm Metastasis Colorectal Neoplasms, Hereditary Nonpolyposis DNA, Neoplasm Genetic Predisposition to Disease Stomach Neoplasms Adenocarcinoma, Clear Cell Retrospective Studies Cystadenocarcinoma, Papillary Receptors, Progesterone Neoplasm Recurrence, Local Survival Rate Odds Ratio Skin Neoplasms Survival Analysis Antineoplastic Agents, Hormonal Progestins Neoplasms, Cystic, Mucinous, and Serous Estrogen Replacement Therapy Mice, Nude Prospective Studies Uterine Cervical Neoplasms Receptors, Estrogen Colorectal Neoplasms Follow-Up Studies Reverse Transcriptase Polymerase Chain Reaction Incidence Risk Assessment Registries Mutation Neoplasm Grading Salpingectomy Adenocarcinoma, Mucinous Antineoplastic Agents Adenocarcinoma, Papillary United States Kidney Neoplasms RNA, Messenger DNA Methylation Age Factors Thyroid Neoplasms Genotype Liver Neoplasms Urinary Bladder Neoplasms Disease Progression Cohort Studies Antigens, Neoplasm Disease-Free Survival Estrogen Antagonists Germ-Line Mutation Cell Proliferation Contraceptives, Oral PTEN Phosphohydrolase Antineoplastic Combined Chemotherapy Protocols Mixed Tumor, Mullerian Neoplasms, Hormone-Dependent Gene Expression Profiling Carcinoma, Squamous Cell Drug Resistance, Neoplasm Blotting, Western MutS Homolog 2 Protein Body Mass Index Neoplasm Transplantation Sensitivity and Specificity Lymph Node Excision Cancer Vaccines

No FAQ available that match "malignant screening endometrial cancer vulvar neoplasms"